-
Overview of the National Cancer Institute (NCI) Nanotechnology Characterizaton Laboratory (NCL)
03 Nov 2014 | Contributor(s): Jennifer Hall Grossman
Working in concert with the National Institute of Standards and Technology (NIST) and the U.S. Food and Drug Administration (FDA), the National Cancer Institute (NCI) established the Nanotechnology Characterization Laboratory to perform preclinical efficacy and toxicity testing of...
-
pRainBow optical barcoding library
14 Aug 2014 | Reagents | Contributor(s): Andries Zijlstra
Note: this is a work in progress. About: pRainBow is a library of lentiviral vectors designed to allow for fluorescent labeling of cells with one of 7 distinct fluorescent proteins. Composition: How to obtain: How to cite: Other information:Good global...
-
Rationale for Creating an International Forum and NCI Funding Opportunities
18 Apr 2014 | Presentations | Contributor(s): Larry Clarke
The topic here is the creation of research networks and their value to cancer research.The Cancer Imaging Program, is administering several research networks. This presentation on the creation and value of two of them (The Network for Translational research or NTR, and the Quantitative Imaging...
-
Read across in nanosafety research: Dissolution behaviour of a library of 37 nanomaterials in simplified physiological media
05 Nov 2019 | Presentations | Contributor(s): Tassos Papadiamantis, Emily Guggenheim, Antreas Afantitis, Sophie Briffa, Georgia Melagraki, Iseult Lynch, Eugenia Valsami-Jones
NanoWorkingGroup, 31 October 2019The dissolution of engineered nanomaterials (ENMs) is a complex process, which remains poorly understood despite being one of the key prerequisites for the risk assessment of ENMs, and having a direct influence on toxicological and eco-toxicological effects....
-
Report to the DICOM Standards Committee - December 4, 2015
10 Dec 2014 | Downloads | Contributor(s): Joseph Kalen
-
Screening for Small Molecules: Target Discovery Against miRNAs for Breast Cancer Treatment
18 Aug 2015 | Presentations | Contributor(s): Odemaris Narvaez del Pilar
Breast cancer is one of the leading causes of cancer related deaths and morbidity among women worldwide. Identifying new targets and developing new therapies is very important in order to improve patient outcomes and minimize this health burden. MicroRNAs, a type of non-coding RNA, are potential...
-
Some thoughts on our progress in defining and advancing nanoinformatics
06 Nov 2018 | Presentations | Contributor(s): Mark D Hoover
Nano WG presentation November 1, 2018 by Mark Hoover, NIOSH Discussion on Nano WG accomplishments, goals and future directions.
-
Some thoughts on our progress in defining and advancing nanoinformatics
01 Aug 2019 | Presentations | Contributor(s): Mark D Hoover
Nano WG Meeting November 1, 2018Discussion on Nano WG accomplishments and future directions.
-
Some Thoughts on Reproducibility
05 Dec 2014 | Presentations | Contributor(s): John Rumble
Nano WG December 4, 2014
-
Summary of the 2015 Epigenetic Engineering for Cancer Workshops
22 Dec 2015 | Publications | Contributor(s): Tony Dickherber
This document provides a general summary of the 2 virtual workshops held in Fall of 2015 to explore the suitability of epigenetic engineering tools to specifically modify epigenetic loci to study and/or treat cancer.
-
Transitioning to Predictive Analysis for Nanoparticle Biocorona Studies
14 May 2019 | Presentations | Contributor(s): Korin Wheeler
Nano WG April 18, 2019: Proteins adsorbed to nanomaterials in a biological environment mediate cellular recognition, uptake, and toxicity of nanomaterials. Here, Dr. Korin Wheeler presents the development of experimental methods to characterize this population of proteins (also...
-
Translational Cancer Imaging
18 Apr 2014 | Presentations | Contributor(s): Tony Ng, David Hawkes, Shonit Punwani
-
Workshop Tweets
15 Aug 2017 | Publications | Contributor(s): Stephanie Morris
Collated tweets from workshop and networking reception.